From: Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?
Efficacy | Side-effect profile | Cost | ||||
---|---|---|---|---|---|---|
Patient | Self | Patient | Self | Patient | Self | |
Most important | 475 (84.8%) | 404 (77.8%) | 191 (34.5%) | 237 (46.4%) | 17 (3.2%) | 13 (2.7%) |
2nd most important | 84 (15%) | 115 (22.2%) | 326 (59%) | 258 (50.1%) | 91 (17.2%) | 69 (14.2%) |
Least important | 1 (0.2%) | 0 | 36 (6.5%) | 16 (3.1%) | 422 (79.6%) | 405 (83.2%) |